Group | CE | HA | χ2/t/z | P | |
---|---|---|---|---|---|
Cases | 52 | 50 | |||
Age (years) | 78.00 ± 6.95 | 80.04 ± 6.39 | −1.542 | 0.126 | |
Gender, n(%) | Male | 8 (15.4) | 10 (20.0) | 0.374a | 0.541 |
Female | 44 (84.6) | 40 (80.0) | |||
BMI | 27.26 ± 2.47 | 26.47 ± 2.35 | 1.641 | 0.104 | |
Bone density, M(P1, P3) | −3.1 (− 4.05, − 2.65) | −3.4 (− 3.8, − 3) | −1.473 | 0.141 | |
AO/OTA classification, n(%) | |||||
31-A1 | 1(1.9) | 1(2.0) | 0.049 a | 0.976 | |
31-A2 | 44(84.6) | 43(86.0) | |||
31-A3 | 7(13.5) | 6(12.0) | |||
Age-adjusted CCI | 4.115 ± 1.06 | 4.4 ± 0.83 | 1.504 | 0.136 | |
ASA score, n(%) | III | 25(48.1) | 22(44.0) | 0.171 a | 0.679 |
IV | 27(51.9) | 28(56.0) | |||
Comorbidities diseases, n(%) | |||||
Cardiovascular | 17(32.7) | 18(36.0) | 0.124 a | 0.725 | |
Respiratory | 4((7.7) | 6(12.0) | 0.159b | 0.690 | |
Neurologic disease | 5(9.6) | 4(8.0) | 0.004 b | 0.951 | |
Diabetes | 15(28.8) | 17(34.0) | 0.315 a | 0.575 | |
Urinary | 2(3.8) | 3(6.0) | 0.002 b | 0.964 |